Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Johnson & Johnson (

3 Dividend Stocks to Buy for a Safe Haven in This Volatile Market

The consistency in their dividend payments makes them dependable stocks in a volatile market.

Barchart

Resilient Investing: 3 Stocks Built to Weather Market Volatility

Resilient companies with strong financials and diverse revenue in healthcare, technology, and essential services can offer stability in volatile markets.

MarketBeat

Is Johnson & Johnson Stock Underperforming the Dow?

Despite Johnson & Johnson’s underperformance relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Dividend-Paying Stocks Bucking the Market’s Trend

Despite a relentless market-wide selloff on Friday, Coca-Cola, Johnson & Johnson, and McDonald’s showed notable strength, defying the broader downtrend.

MarketBeat

3 "Forever Stocks" You Can Buy and Hold for Decades

Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in the economic and geopolitical spheres. In this volatile environment, investors may find value in fundamentally stable stocks like Microsoft (MSFT), Alphabet (GOOGL), and Johnson & Johnson (JNJ). Continue to read….

StockNews.com

Thousands to sue Johnson & Johnson in UK over alleged talc link to cancer

Group action with 3,500 claimants alleges company knew its talcum powder products contained dangerous asbestos

The Guardian - UK

Johnson & Johnson Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Johnson & Johnson's underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

2 Dividend Kings You Should Snap Up Immediately

Recent earnings from these dividend-paying companies reflects their stability.

Barchart

How tech leaders are rethinking their cloud strategies in the face of fast-rising costs

As spending on cloud computing rises sharply amid the generative AI boom, executives are on the hunt for cost savings.

Fortune

3 Stocks Upgraded by Bank of America – Here's Why They're Bullish

Bank of America analysts have recently shifted their views on these three stocks, leaving investors with a few points to consider.

MarketBeat

Technology Stocks Upended by China’s DeepSeek

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -1.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.97%. March E-mini S&P futures (ESH25 ) are down by -1.38%, and March E-mini Nasdaq...

Barchart

Why Traders Are Buying the Dip on Johnson & Johnson Stock

Shares of Johnson & Johnson stock have declined by 11.5% in the quarter, and markets are calling for a bottom and rally here.

MarketBeat

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

MarketBeat

Ketamine-derived nasal spray for depression now FDA-approved as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stocks March Higher as Netflix and Oracle Soar

The S&P 500 Index ($SPX ) (SPY ) today is up +0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. March E-mini S&P futures (ESH25 ) are up +0.52%, and March E-mini Nasdaq futures...

Investors Business Daily

J&J Skids After Dow Giant Beat Earnings Views, But 'Prudent' Guidance Disappoints

Johnson & Johnson stock gapped down Wednesday after the health care giant issued light 2025 sales guidance, taking a hit from exchange rates.

MarketBeat

Is Johnson & Johnson Stock Set to Reward Long-Term Holders?

JNJ stock is up 1.8% after announcing its $14.6 billion acquisition of Intra-Cellular Therapeutics, which may make this undervalued dividend king attractive

The Independent UK

Stock market today: Asian shares trade mixed after drops for Big Tech leave Wall Street mixed

Asian shares are mixed after gains for oil-and-gas producers helped offset drops for Nvidia and other Big Tech companies on Wall Street

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Largest ever protein study set to revolutionise cancer and dementia tests

Tens of millions of pounds in investment is being provided by the group of firms which includes AstraZenecaa and Pfizer

Evening Standard

World’s largest proteins study ‘invaluable’ for understanding disease – experts

The scaled-up project is backed by a consortium of 14 pharmaceutical firms.

Investors Business Daily

J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Barchart

Top 3 Discounted Dividend Stocks for 2025 That Could Skyrocket Your Portfolio

These three companies are leaders in their field, have a long history of increasing their dividends, and the stocks trade at a discount.

Barchart

Johnson & Johnson's Quarterly Earnings Preview: What You Need to Know

Johnson & Johnson is poised to release its fiscal fourth-quarter earnings this month, and analysts project a double-digit profit decline.

The Independent UK

‘I felt betrayed’: Woman blames cancer diagnosis on talcum powder use

Exclusive: Jane Campbell is one of thousands of women in the UK planning legal action against one of the world’s largest pharmaceutical firms over alleged links between talc and cancer

The Independent UK

Man sues Johnson & Johnson for $25m claiming talcum powder killed his wife

The lawsuit, filed in Maine, claims Cynthia Cartwright ingested asbestos while using the product, Pecos River Talc, which is a subsidiary of the pharmeceutical giant

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.